Power Law company profile

Omeros

Biotech & Life Sciences · Charlottesville, United States · Founded 1994 · IPO 2009 Thoroughbred

Developing therapeutics for immunological and central nervous system disorders

Valuation

$1.12B

Market cap · May/2026

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on Omeros's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Aravis Ventures

ARCH Venture Partners

Trevi Health Ventures

The Grosvenor Funds

Stanley Medical Research Institute

Novartis Venture Fund

Southern Cross Venture Partners

Global footprint

Where Omeros has talent and traffic

AI talent share

0.9% of workforce is AI talent
(2 of 219 staff)

Core AI00%

Other AI20.91%

Non-AI workforce21799.09%

Workforce by country

3 countries with
team presence

🇺🇸 United States98.7%

🇬🇧 United Kingdom0.6%

🇮🇹 Italy0.6%

3 countries shown

Web traffic by country

14K monthly visits
across markets

🇺🇸 United States57.9%

🇬🇧 United Kingdom12.9%

🏳️ Korea8.6%

🏳️ Republic of8.6%

🇮🇳 India7.9%

Top 5 markets shown

Market sentiment

What the market is saying about Omeros

An AI-synthesized read of the highest-engagement posts about Omeros on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Omeros on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles